Wondering whether your cholestatic patient might benefit from genetic testing and which genes to include? 🧬
Check out this paper 👉🏼 https://t.co/ytyyKdvrAE
Grateful to our patients and the incredible team Luisa Ronzoni @lalicristos @MCarbone_80@lucavalenti75#LiverTwitter
Whatever you need to navigate PSC, we’ve got your back.
✅ Specialist Helpline Nurse
✅ Medically-verified info
✅ Private peer support group
✅ Live webinars & In-person events
Connect with the #PSCcommunity and learn more about available support.
➡️ https://t.co/vLwbz7lHxh
PSC research is challenging, but progress is happening faster than ever. There are now more clinical trials testing potential treatments than ever. Every study brings us closer to better care and, one day, a cure.
👉 https://t.co/tZbNGHhtzu #LetsBeatPSC#PSCResearch
🛍️ Amazon Prime Days are here (7–8 Oct)!
Shop amazing deals & raise FREE donations for PSC Support through @easyuk. It costs you nothing! Every purchase funds vital research & support.
👉 Join here: https://t.co/pcSlXNMyTC
#AmazonPrimeDay#PSCSupport#LetsBeatPSC
October is #LiverCancerAwarenessMonth, focusing on early detection, support for those with liver cancer, and remembering loved ones. People with #PSC face higher cancer risks and should discuss screening with their doctors.
➡️ https://t.co/pShfvyHfJp #LetsBeatPSC@LiverTrust
Wrapping up the 3rd YI workshop of the International PSC Study Group in Amsterdam. Fancy science, fancy network, fancy location! Thanks to Prof. Cyriel Ponsioen and @amsterdamumc for hosting!
For people with PSC, patient safety means being heard, advocating for their health, and having tools to support urgent decision-making. Our free PSC Alert Card (physical or digital) helps patients & clinicians act fast when acute cholangitis is suspected. https://t.co/3Bgl8OzRGF
This #PBCAwarenessDay we’re shining a light on the differences between PBC and PSC and available support. Both affect the liver, but they're distinct diseases. @PBCFoundation and @PSCSupport are here to help. You are not alone. https://t.co/uxfWmuEdBD
#PBCAwareness#PSCAwareness
🔴Now LIVE on #EASLStudio
Treating #PBC: ALP response or liver stiffness?
Experts debate the relevance of biochemical & imaging endpoints in today’s therapeutic landscape.
🔗https://t.co/xiZtXbO6NB
@Mcarbone_80@PBCers @PBCFoundation
#LiverX
We’ll all be remembered for something...dance moves, bakes, jokes, cheeky smile. This #RememberACharityWeek, you could also be remembered for making a difference by leaving a gift to PSC Support in your Will. 👉https://t.co/kbwKiygUvB #LetsBeatPSC#RareDisease#LegacyGiving
Just 1 week to go! Ever wondered about the different types of PSC? What is small-duct PSC and how is it different? There’s still time to register join us for our next live Ask the Expert session: https://t.co/lQbLOuAoVa
#LetsBeatPSC#LiverHealth#PSCSupport#AskTheExpert
Excited to share that our paper about Claudin-1 in primary sclerosing cholangitis is now published in the @JHepatology!
Grateful to family, mentors, @LiverStrasbourg staff, and collaborators!
Check it out at https://t.co/5apcwmD0uL
Nutrition plays a key role in liver health. We’ve created a series of low-sodium, cirrhosis-friendly recipes with step-by-step chef videos — from egg bites to margherita pizza — for you to share with patients!
#LiverTwitter
Terrific editorial by Mezzacappa and Lupe GGT
1. Antibiotic prophylaxis in cirrhosis with UGIB should be examined carefully
2. A meta-analysis of old and unrepresentative studies sadly cannot answer any questions
🚨Long-term use of low-dose prednisone was associated with higher recurrence Primary Sclerosing Cholangitis recurrence after liver transplantation‼️
#LiverX@AEEHLiver@sepdigestiva
Apologies @PMRodrigues19 but the link to the full video did not work in the original post. Here's the correct link: https://t.co/GQfriIYZ3G
Thanks again for giving us your time and for this encouraging update. ^Emily
Nice systematic analysis of gene convergence between common and rare variant GWAS discoveries.
Not often we see common and rare variant studies implicating the same set of genes for a trait. This convergence is rare particularly for traits under strong selection like early onset neuropsychiatric diseases.
However, if we take a step backward, we can see that, even though common and rare disease variants do not converge on the same genes, they do converge on the same pathways.
Analyzing 373 phenotypes with both common and rare variant discoveries available, the authors find that genes implicated by rare and common variants implicate the same pathways for >75% of traits.
Paper:
Wright et al. Common and rare genetic variants show network convergence for a majority of human traits. medRxiv 2025
https://t.co/dVQvxHnBye